Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mortimer

Showing results (261-270 of 262) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 262 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trialSusanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.
Pageof 27

Showing results (261-270 of 262) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 262 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trialSusanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.
Pageof 27